SEATTLE, WA--(Marketwire - April 03, 2008) - Pacific Biometrics, Inc. (PBI) (OTCBB: PBME) has been awarded a series of contracts with a top multinational pharmaceutical company (the “Sponsor”) to provide essential laboratory data for a global Phase I and Phase II metabolic disease program. These contracts are part of a series of seven contracts related to clinical trials that form part of a global development program for an innovative approach for the treatment of type 2 diabetes and obesity.
